188 related articles for article (PubMed ID: 37774369)
21. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
[TBL] [Abstract][Full Text] [Related]
22. Increased local concentration of complement C5a contributes to incisional pain in mice.
Jang JH; Liang D; Kido K; Sun Y; Clark DJ; Brennan TJ
J Neuroinflammation; 2011 Jul; 8():80. PubMed ID: 21736743
[TBL] [Abstract][Full Text] [Related]
23. Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease.
Sadler KE; Langer SN; Menzel AD; Moehring F; Erb AN; Brandow AM; Stucky CL
Br J Haematol; 2019 Oct; 187(2):246-260. PubMed ID: 31247672
[TBL] [Abstract][Full Text] [Related]
24. Descending Facilitation of Nociceptive Transmission From the Rostral Ventromedial Medulla Contributes to Hyperalgesia in Mice with Sickle Cell Disease.
Rogness VM; Juliette J; Khasabova IA; Gupta K; Khasabov SG; Simone DA
Neuroscience; 2023 Aug; 526():1-12. PubMed ID: 37330194
[TBL] [Abstract][Full Text] [Related]
25. Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease.
Cataldo G; Rajput S; Gupta K; Simone DA
Pain; 2015 Apr; 156(4):722-730. PubMed ID: 25630029
[TBL] [Abstract][Full Text] [Related]
26. Levels of Soluble Endothelium Adhesion Molecules and Complications among Sickle Cell Disease Patients in Ghana.
Antwi-Boasiako C; Donkor ES; Sey F; Dzudzor B; Dankwah GB; Otu KH; Doku A; Dale CA; Ekem I
Diseases; 2018 Apr; 6(2):. PubMed ID: 29690499
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
Harris EM; Vilk E; Heeney MM; Solodiuk J; Greco C; Archer NM
Pediatr Blood Cancer; 2021 Jul; 68(7):e28989. PubMed ID: 33788404
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
[TBL] [Abstract][Full Text] [Related]
29. Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.
Vats R; Tutuncuoglu E; Pradhan-Sundd T; Tejero J; Shaw GD; Sundd P
Exp Hematol; 2020 Apr; 84():1-6.e1. PubMed ID: 32243995
[TBL] [Abstract][Full Text] [Related]
30. Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.
Tchernychev B; Li H; Lee SK; Gao X; Ramanarasimhaiah R; Liu G; Hall KC; Bernier SG; Jones JE; Feil S; Feil R; Buys ES; Graul RM; Frenette PS; Masferrer JL
Br J Pharmacol; 2021 Sep; 178(17):3463-3475. PubMed ID: 33864386
[TBL] [Abstract][Full Text] [Related]
31. Comparative Analysis of Pain Behaviours in Humanized Mouse Models of Sickle Cell Anemia.
Lei J; Benson B; Tran H; Ofori-Acquah SF; Gupta K
PLoS One; 2016; 11(8):e0160608. PubMed ID: 27494522
[TBL] [Abstract][Full Text] [Related]
32. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
33. Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.
Calhoun G; Wang L; Almeida LE; Kenyon N; Afsar N; Nouraie M; Finkel JC; Quezado ZM
Eur J Pharmacol; 2015 May; 754():125-33. PubMed ID: 25724786
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
35. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
[TBL] [Abstract][Full Text] [Related]
36. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
[TBL] [Abstract][Full Text] [Related]
37. Cold hypersensitivity increases with age in mice with sickle cell disease.
Zappia KJ; Garrison SR; Hillery CA; Stucky CL
Pain; 2014 Dec; 155(12):2476-2485. PubMed ID: 24953902
[TBL] [Abstract][Full Text] [Related]
38. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
Morris CR; Brown LAS; Reynolds M; Dampier CD; Lane PA; Watt A; Kumari P; Harris F; Manoranjithan S; Mendis RD; Figueroa J; Shiva S
Blood; 2020 Sep; 136(12):1402-1406. PubMed ID: 32384147
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.
Vincent L; Vang D; Nguyen J; Benson B; Lei J; Gupta K
Haematologica; 2016 May; 101(5):566-77. PubMed ID: 26703965
[TBL] [Abstract][Full Text] [Related]
40. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
